Business Description
This actively managed ETF focuses on companies working to advance genomics and precision medicine, including areas such as disease detection, genetic research, and targeted treatments. At least 80% of its assets are invested in this space under normal market conditions. The fund is non-diversified and is managed by Corgi Strategies LLC.
